CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
ClearSight HPI Monitoring system +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05906368
NCT05906368N/ACompleted

Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension -- Pilot Study

Grace Lim, MD, MS·interventional·Posted Jun 15, 2023·Updated Nov 4, 2025

In Brief

A clinical study evaluating ClearSight HPI Monitoring system and Standard of Care Blood Pressure Monitoring for Anesthesia, Epidural and Hypotension. Completed, enrolled 34 participants across 1 site.

Detailed Summary

The purpose of this pilot trial is to examine the feasibility and ease of use of monitoring by ClearSight in laboring and delivering patients with the intent to compare time-to-treatment of hypotension between conventionally monitored patients (Group CM) and those receiving HPI (Group CM + HPI) monitoring by ClearSight, in a population of healthy laboring women who receive epidural analgesia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedJun 15, 2023
Enrollment StartApr 18, 2024
Primary CompletionAug 29, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.0 years ago

Interventions

ClearSight HPI Monitoring systemother

Continuous blood pressure monitoring for precision hypotensive event response

Standard of Care Blood Pressure Monitoringother

Blood pressure (BP) monitoring using a conventional arm cuff and inflation after epidural anesthesia as standard procedure. Standard of care blood pressure monitoring includes measurement of blood pressure at the time of epidural test dose delivery, 3-minute cycles of BP monitoring for 30 minutes after epidural placement, and then BP monitoring every 15 minutes per existing clinical standards for at least 4-hours, or until delivery.